Synjardy XR 12.5 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 12.5 mg/1

Synjardy XR 12.5 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to support blood sugar management in adults with type 2 diabetes. This medication is intended for oral use and is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

Strength

12.5 mg/1

Pack Size

180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0300-93)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 12.5 mg/1 is commonly used to help manage blood sugar levels in adults with type 2 diabetes. The combination of empagliflozin and metformin hydrochloride works to improve glycemic control. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise.

Side Effects

Common effects of Synjardy XR 12.5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals may experience urinary tract infections or hypoglycemia. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Synjardy XR 12.5 mg/1 should be handled with care, especially for individuals with kidney problems or a history of pancreatitis. It is important to follow the prescribed dosage and administration instructions. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Synjardy XR 12.5 mg/1 may interact with certain medications, including diuretics, insulin, and other drugs that affect blood sugar levels. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always consult a healthcare provider before starting any new medication.

Frequently Asked Questions

Synjardy XR 12.5 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.

Synjardy XR 12.5 mg/1 is an extended-release tablet taken orally, typically once daily with a meal.

Common side effects may include nausea, diarrhea, headache, and urinary tract infections.

It is important to consult a healthcare provider before taking Synjardy XR 12.5 mg/1 with other medications to avoid potential interactions.

Synjardy XR 12.5 mg/1 may not be suitable for individuals with certain medical conditions, such as kidney problems or a history of pancreatitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.